.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
US Department of Justice
Chinese Patent Office
Teva
US Army
AstraZeneca
Colorcon
Farmers Insurance
McKinsey
Daiichi Sankyo

Generated: December 13, 2017

DrugPatentWatch Database Preview

REBETOL Drug Profile

« Back to Dashboard

When do Rebetol patents expire, and what generic alternatives are available?

Rebetol is a drug marketed by Merck Sharp Dohme and Schering and is included in two NDAs. There are six patents protecting this drug.

The generic ingredient in REBETOL is ribavirin. There are fifteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ribavirin profile page.
Drug patent expirations by year for REBETOL

Pharmacology for REBETOL

Medical Subject Heading (MeSH) Categories for REBETOL

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Merck Sharp DohmeREBETOLribavirinCAPSULE;ORAL020903-001Jun 3, 1998DISCNNoNo► Subscribe► Subscribe► SubscribeY► Subscribe
Merck Sharp DohmeREBETOLribavirinCAPSULE;ORAL020903-002Jul 25, 2001ABRXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Merck Sharp DohmeREBETOLribavirinCAPSULE;ORAL020903-001Jun 3, 1998DISCNNoNo► Subscribe► Subscribe► SubscribeY► Subscribe
ScheringREBETOLribavirinSOLUTION;ORAL021546-001Jul 29, 2003RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Merck Sharp DohmeREBETOLribavirinCAPSULE;ORAL020903-002Jul 25, 2001ABRXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
ScheringREBETOLribavirinSOLUTION;ORAL021546-001Jul 29, 2003RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
ScheringREBETOLribavirinSOLUTION;ORAL021546-001Jul 29, 2003RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Merck Sharp DohmeREBETOLribavirinCAPSULE;ORAL020903-001Jun 3, 1998DISCNNoNo► Subscribe► Subscribe► SubscribeY► Subscribe
Merck Sharp DohmeREBETOLribavirinCAPSULE;ORAL020903-001Jun 3, 1998DISCNNoNo► Subscribe► Subscribe► SubscribeY► Subscribe
Merck Sharp DohmeREBETOLribavirinCAPSULE;ORAL020903-002Jul 25, 2001ABRXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: REBETOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
ScheringREBETOLribavirinSOLUTION;ORAL021546-001Jul 29, 2003► Subscribe► Subscribe
Merck Sharp DohmeREBETOLribavirinCAPSULE;ORAL020903-001Jun 3, 1998► Subscribe► Subscribe
Merck Sharp DohmeREBETOLribavirinCAPSULE;ORAL020903-002Jul 25, 2001► Subscribe► Subscribe
Merck Sharp DohmeREBETOLribavirinCAPSULE;ORAL020903-001Jun 3, 1998► Subscribe► Subscribe
Merck Sharp DohmeREBETOLribavirinCAPSULE;ORAL020903-002Jul 25, 2001► Subscribe► Subscribe
ScheringREBETOLribavirinSOLUTION;ORAL021546-001Jul 29, 2003► Subscribe► Subscribe
ScheringREBETOLribavirinSOLUTION;ORAL021546-001Jul 29, 2003► Subscribe► Subscribe
ScheringREBETOLribavirinSOLUTION;ORAL021546-001Jul 29, 2003► Subscribe► Subscribe
Merck Sharp DohmeREBETOLribavirinCAPSULE;ORAL020903-001Jun 3, 1998► Subscribe► Subscribe
Merck Sharp DohmeREBETOLribavirinCAPSULE;ORAL020903-001Jun 3, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Farmers Insurance
Covington
Cipla
Express Scripts
Queensland Health
Teva
Citi
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot